Literature DB >> 79

Studies on electron transfer between mercury electrode and hemoprotein.

F Scheller, M Jänchen, J Lampe, H J Prümke, J Blanck, E Palecek.   

Abstract

The electrochemical behaviour of ferricytochrome c, metmyoglobin and methemoglobin was studied using d.c., a.c. and differential pulse polarography, and controlled potential electrolysis. 1. The three hemoproteins yield d.c. polarographic steps, and peaks in differential pulse polarograms, the height of which is proportional to concentration. The charge transfer is influenced by strong adsorption. 2. The concentration dependence of the a.c. polarograms indicates structural changes in the adsorbed molecules. 3. The reduction products of controlled potential electrolysis of metmyoglobin and methemoglobin have absorption spectra identical with the native control samples. The affinity for oxygen and the cooperativity in hemoglobin are not affected by the reaction at the electrode. 4. The charge transfer proceeds via adsorbed, already reduced, molecules to freely diffusible proteins.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 79     DOI: 10.1016/0005-2795(75)90348-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

Review 1.  Cognitive behavioural therapy in cystic fibrosis.

Authors:  Karen Heslop
Journal:  J R Soc Med       Date:  2006       Impact factor: 5.344

2.  Researching breathlessness in palliative care: consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup.

Authors:  S Dorman; C Jolley; A Abernethy; D Currow; M Johnson; M Farquhar; G Griffiths; T Peel; S Moosavi; A Byrne; A Wilcock; L Alloway; C Bausewein; I Higginson; S Booth
Journal:  Palliat Med       Date:  2009-02-27       Impact factor: 4.762

3.  Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis.

Authors:  Stephen Allen; Satru Raut; Jane Woollard; Michael Vassallo
Journal:  Palliat Med       Date:  2005-03       Impact factor: 4.762

4.  An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses.

Authors:  Paul N Lanken; Peter B Terry; Horace M Delisser; Bonnie F Fahy; John Hansen-Flaschen; John E Heffner; Mitchell Levy; Richard A Mularski; Molly L Osborne; Thomas J Prendergast; Graeme Rocker; William J Sibbald; Benjamin Wilfond; James R Yankaskas
Journal:  Am J Respir Crit Care Med       Date:  2008-04-15       Impact factor: 21.405

Review 5.  A systematic review of the use of opioids in the management of dyspnoea.

Authors:  A-L Jennings; A N Davies; J P T Higgins; J S R Gibbs; K E Broadley
Journal:  Thorax       Date:  2002-11       Impact factor: 9.139

6.  How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer.

Authors:  J M Gore; C J Brophy; M A Greenstone
Journal:  Thorax       Date:  2000-12       Impact factor: 9.139

7.  Opiate therapy in chronic cough.

Authors:  Alyn H Morice; Madhav S Menon; Siobhan A Mulrennan; Caroline F Everett; Caroline Wright; Jennifer Jackson; Rachel Thompson
Journal:  Am J Respir Crit Care Med       Date:  2006-11-22       Impact factor: 21.405

8.  Palliative care services for those with chronic lung disease.

Authors:  M R Partridge; A Khatri; L Sutton; S Welham; S H Ahmedzai
Journal:  Chron Respir Dis       Date:  2009       Impact factor: 2.444

Review 9.  Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases.

Authors:  C Bausewein; S Booth; M Gysels; I Higginson
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

10.  An integrated model of provision of palliative care to patients with cystic fibrosis.

Authors:  S J Bourke; S J Doe; A D Gascoigne; K Heslop; M Fields; D Reynolds; K Mannix
Journal:  Palliat Med       Date:  2009-05-21       Impact factor: 4.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.